News Category
Lantern Pharma's upcoming Q2 2026 webcast will detail financial results and provide crucial updates on its AI-driven oncology pipeline and commercial ...
Lantern Pharma (NASDAQ: LTRN) received a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investiga...
Formycon AG partners with OneSource Specialty Pharma to leverage India-based manufacturing for cost-efficient, scalable biosimilar production, aiming ...
Lantern Pharma's launch of ZetaOmics, an autonomous computational biologist agent within its multi-agentic AI co-scientist platform, aims to automate ...
Academy Hunt's database now exceeds 1,000 course comparisons, helping learners in Bangalore and across India evaluate AI, machine learning, and data s...
Quantum Genesis AI Corp. issues a statement to distinguish its research activities from those of Quantumzyme LLP and clarify intellectual property rig...
Lantern Pharma closed a $4.4 million registered direct offering, using proceeds to advance its AI-driven precision oncology pipeline and expanding its...
Lantern Pharma's expansion of its predictBBB platform into a Large Quantitative Model enhances drug discovery by providing real-time, web-based molecu...
Lantern Pharma announces a live demonstration of its withZeta.ai multi-agentic AI platform, showcasing its ability to accelerate oncology drug discove...
